{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:43:06Z","timestamp":1790142186827,"version":"4.0.1"},"reference-count":43,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1485,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1111\/j.1751-7176.2011.00515.x","type":"journal-article","created":{"date-parts":[[2011,8,8]],"date-time":"2011-08-08T19:00:52Z","timestamp":1312830052000},"page":"649-653","source":"Crossref","is-referenced-by-count":93,"title":["\u03b2-Adrenergic Blockers"],"prefix":"10.1111","volume":"13","author":[{"given":"William H.","family":"Frishman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elijah","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,8,8]]},"reference":[{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/bmj.1.5392.1227","article-title":"Hypotensive action of pronethalol","volume":"1","author":"Prichard","year":"1964","journal-title":"Br Med J"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/bmj.2.5411.725","article-title":"Use of propranolol (Inderal) in the treatment of hypertension","volume":"2","author":"Prichard","year":"1964","journal-title":"Br Med J"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB3|cit3","first-page":"57","volume-title":"Cardiovascular Pharmacotherapeutics","author":"Frishman","year":"2011"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB4|cit4","first-page":"446","volume-title":"Hypertension Primer, 4th ed.: The Essentials of High Blood Pressure","author":"Frishman","year":"2008"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/00132580-200211000-00005","article-title":"Comprehensive management of hypertensive emergencies and urgencies","volume":"4","author":"Mansoor","year":"2002","journal-title":"Heart Dis"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.279.23.1903","article-title":"Are beta blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review","volume":"279","author":"Messerli","year":"1998","journal-title":"JAMA"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.jacc.2008.08.008","article-title":"Beta blockers in hypertension. Adding insult to injury (editorial comment)","volume":"52","author":"Kaplan","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.304.6824.405","article-title":"MRC Working Party. Medical research council trial of treatment of hypertension in older adults: principal results","volume":"304","year":"1992","journal-title":"Br Med J"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3109\/10641969309037083","article-title":"MRC trial of treatment in elderly hypertensives","volume":"15","author":"Lever","year":"1993","journal-title":"Clin Exp Hypertens"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","article-title":"Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA), a multicentre randomised controlled trial","volume":"366","author":"Dahlof","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.jacc.2011.01.008","article-title":"ACCF\/AHA 2010 Expert Consensus Document on Hypertension in the Elderly. A report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents, in collaboration with the American Academy of Neurology, Association of Black Cardiologists, American Geriatrics Society, American Society of Hypertension, American Society of Nephrology, American Society for Preventive Cardiology, and the European Society of Hypertension","volume":"57","author":"Aronow","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(05)67573-3","article-title":"Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis","volume":"366","author":"Lindholm","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1503\/cmaj.060110","article-title":"Reexamining the efficacy of beta blockers for the treatment of hypertension: a meta analysis","volume":"174","author":"Khan","year":"2006","journal-title":"CMAJ"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1161\/CIRCULATIONAHA.105.595496","article-title":"Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAF\u00c9) study","volume":"113","author":"Williams","year":"2006","journal-title":"Circulation"},{"issue":"suppl 3","key":"10.1111\/j.1751-7176.2011.00515.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1524-6175.2007.06633.x","article-title":"A historical perspective on the development of \u03b2-adrenergic blockers","volume":"9","author":"Frishman","year":"2007","journal-title":"J Clin Hypertens"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.amjmed.2008.06.025","article-title":"Fifty years of beta-adrenergic blockade: a golden era in clinical medicine and molecular pharmacology (commentary)","volume":"121","author":"Frishman","year":"2008","journal-title":"Am J Med"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/j.1524-6175.2007.07548.x","article-title":"The efficacy and tolerability of nebivolol in hypertensive African American patients","volume":"9","author":"Saunders","year":"2007","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/01.crd.0000137738.16166.cc","article-title":"Pathophysiology and medical management of systemic hypertension in pregnancy","volume":"13","author":"Frishman","year":"2005","journal-title":"Cardiol Rev"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB19|cit19","first-page":"565","article-title":"\u03b2-Adrenergic blockers: a 50-year historical perspective","volume":"15","author":"Frishman","year":"2008","journal-title":"Am J Ther"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1056\/NEJM198304213081606","article-title":"Drug therapy: pindolol: a new beta-adrenoceptor antagonist with partial agonist activity","volume":"308","author":"Frishman","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1056\/NEJM199812103392407","article-title":"Carvedilol","volume":"339","author":"Frishman","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/01.crd.0000223651.03023.8e","article-title":"Nebivolol, a new therapy update","volume":"14","author":"Sule","year":"2006","journal-title":"Cardiol Rev"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJM198403293101306","article-title":"Beta-adrenergic blockade for survivors of acute myocardial infarction","volume":"310","author":"Frishman","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0002-9343(03)00158-X","article-title":"A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension","volume":"115","author":"Klingbeil","year":"2003","journal-title":"Am J Med"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/S0140-6736(10)60960-9","article-title":"Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial","volume":"376","author":"Ong","year":"2010","journal-title":"Lancet"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3949\/ccjm.75.7.513","article-title":"Perioperative beta-blockers in noncardiac surgery: evolution of the evidence","volume":"75","author":"Harte","year":"2008","journal-title":"Cleve Clin J Med"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJM199612053352301","article-title":"Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery Multicenter study of perioperative ischemia research group","volume":"335","author":"Mangano","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1056\/NEJM199912093412402","article-title":"The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group","volume":"341","author":"Poldermans","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB29|cit29","first-page":"i","article-title":"Making health care safer: a critical analysis of patient safety practices","volume":"43","author":"Shojania","year":"2003","journal-title":"Evid Rep Technol Assess (Summ)"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB30|cit30","volume-title":"Safe Practices for Better Healthcare - 2006 Update","author":"National Quality Forum","year":"2006"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1016\/j.jacc.2009.07.004","article-title":"ACCF\/AHA focused update on perioperative beta blockade","volume":"54","author":"Fleischmann","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/S0140-6736(08)60601-7","article-title":"Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE Trial): a randomized controlled trial","volume":"371","author":"POISE Study Group","year":"2008","journal-title":"Lancet"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(08)61560-3","article-title":"Perioperative beta blockers in patients having non-cardiac surgery: a meta-analysis","volume":"372","author":"Bangalore","year":"2008","journal-title":"Lancet"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.amjcard.2007.05.057","article-title":"A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus","volume":"8","author":"Bangalore","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1161\/CIRCULATIONAHA.108.828897","article-title":"Antihypertensive efficacy of aliskiren: is hydrochlorothiazide an appropriate benchmark?","volume":"3","author":"Messerli","year":"2009","journal-title":"Circulation"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1001\/jama.292.18.2227","article-title":"Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial","volume":"292","author":"Bakris","year":"2004","journal-title":"JAMA"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.amjmed.2006.10.017","article-title":"Body weight changes with beta-blocker use: results from GEMINI","volume":"120","author":"Messerli","year":"2007","journal-title":"Am J Med"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB38|cit38","first-page":"493","volume-title":"Cardiovascular Pharmacotherapeutics","author":"Cheng-Lai","year":"2011"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure: the JNC-7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1097\/HJH.0b013e328333146d","article-title":"Reappraisal of European guidelines on hypertension management: a European Society of hypertension task force document","volume":"27","author":"Mancia","year":"2009","journal-title":"J Hypertens"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.jacc.2008.06.048","article-title":"Relation of beta-blocker-induced heart rate lowering and cardioprotection in hypertension","volume":"52","author":"Bangalore","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB42|cit42","volume-title":"Clinical Pharmacology of the \u03b2-Adrenoceptor Blocking Drug","author":"Frishman","year":"1984"},{"key":"10.1111\/j.1751-7176.2011.00515.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0025-7125(16)30786-6","article-title":"\u03b2-Adrenergic blockers","volume":"72","author":"Frishman","year":"1988","journal-title":"Med Clin North Am"}],"container-title":["The Journal of Clinical Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1751-7176.2011.00515.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T07:51:52Z","timestamp":1625557912000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1751-7176.2011.00515.x"}},"subtitle":["\u03b2-Adrenergic Blockers"],"short-title":[],"issued":{"date-parts":[[2011,8,8]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1751-7176.2011.00515.x","relation":{},"ISSN":["1524-6175"],"issn-type":[{"value":"1524-6175","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8,8]]}}}